Skip to content

TIVA

Active
Private limited company·Activiteiten van medisch specialisten· 8 yrs active
Monseigneur Callewaertstr.(Mar) 20 ·8510 Kortrijk, Belgium
KBO/BCE: BE 0696.844.040
Watch Print / PDF
Age8 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of TIVA is 0.1% (very low). The 2024 annual accounts show equity of €149k and a net result of €236k. Equity is shrinking by ~11.9% per year across the filed fiscal years. Its solvency ranks better than 21% of 6582 sector peers (fiscal year 2024). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Signals

2 signals · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 6582 sector peers (2024).
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 16 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 14-07-2025, 17 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 7 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 14-07-2025 17 d early 2025-00263229
31-12-2023 31-07-2024 24-07-2024 7 d early 2024-00275844
31-12-2022 31-07-2023 21-07-2023 10 d early 2023-00258030
31-12-2021 31-07-2022 18-07-2022 13 d early 2022-20195730
31-12-2020 31-07-2021 21-07-2021 10 d early 2021-38300468
31-12-2019 31-07-2020 15-07-2020 16 d early 2020-30100396
31-12-2018 31-07-2019 27-08-2019 27 d late 2019-51500586

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2018, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€236k+13.5%
Working capital€-153k

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 14-07-2025 with the NBB · fiscal year 2024 · micro
€0€100k€200k€300kOperating result 2020: €231k€231kNet result 2020: €171k€171kOperating result 2021: €244k€244kNet result 2021: €168k€168kOperating result 2022: €257k€257kNet result 2022: €185k€185kOperating result 2023: €289k€289kNet result 2023: €208k€208kOperating result 2024: €318k€318kNet result 2024: €236k€236k20202021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining Equity: declining trend of ~11.9%/year over 7 fiscal years, indicative, assuming unchanged policy.
€-200k€0€200k€400k€600k2025: €151k (€26k - €277k)2026: €117k (€-84k - €318k)2027: €82k (€-194k - €358k)2018: €182k2019: €358k2020: €521k2021: €289k2022: €356k2023: €150k2024: €149k2018201920202021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 27.3% 66.7%
better than 21% of 6582 sector peers
Net result €236k €46k
better than 95% of 6576 sector peers
Equity €149k €79k
better than 70% of 6582 sector peers
Gross operating margin €422k €78k
better than 95% of 6584 sector peers
Total assets €544k €154k
better than 89% of 6585 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P21
2020: P39 · n=6522021: P22 · n=18482022: P30 · n=36842023: P15 · n=53462024: P21 · n=65822020 2024
Weakening position over 2020-2024 · n=652-6582
Net result P95
2020: P93 · n=6532021: P93 · n=18482022: P95 · n=36822023: P95 · n=53452024: P95 · n=65762020 2024
Stable position over 2020-2024 · n=653-6576
Equity P70
2020: P87 · n=6522021: P88 · n=18482022: P93 · n=36842023: P75 · n=53482024: P70 · n=65822020 2024
Weakening position over 2020-2024 · n=652-6582
Gross operating margin P95
2020: P95 · n=6532021: P95 · n=18492022: P95 · n=36802023: P95 · n=53422024: P95 · n=65842020 2024
Stable position over 2020-2024 · n=653-6584
Describes the position versus peers, not a forecast.
EBITDA
€419k
+9.5% 18-24
Net profit
€236k
+13.5% 18-24
Cash flow
€338k
+11.6% 18-24
Total assets
€544k
-40.3% 18-24
Equity
€149k
-1.2% 18-24
Working capital
€-153k
- 18-24
Income taxes
€73k
+22.5% 18-24
Dividends
€238k
-42.5% 18-24
Show 10 other metrics
Debt
€396k
-48.0% 18-24
Debt ≤ 1y
€388k
-22.5% 18-24
Debt > 1y
€240k
0.0% 18-24
Current ratio
0.61
-39.7% 18-24
Quick ratio
0.61
-39.7% 18-24
Solvency
27.3%
+65.3% 18-24
Debt / equity
2.66
-47.3% 18-24
ROE
159.0%
+15.0% 18-24
ROA
43.4%
+90.1% 18-24
Interest coverage
50.92
+171.4% 18-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€419k
Net profit€236k
Cash flow€338k
Staff costs-
Income taxes€73k
Dividends€238k
Total assets€544k
Equity€149k
Debt€396k
of which ≤ 1y€388k
of which > 1y-
Working capital€-153k
Employees (FTE)-
Ratios (computed)
2024
Current ratio0.61
Quick ratio0.61
Working capital ratio-28.1%
Solvency27.3%
Debt / equity2.66
Long-term debt ratio-
Interest coverage50.92
Gross margin-
Net margin-
ROA43.4%
ROE159.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (20 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€544k
Fixed assets 21/28€310k
Intangible fixed assets 21€248k
Tangible fixed assets 22/27€62k
Current assets 29/58€235k
Cash & bank 54/58€55k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€544k
Equity 10/15€149k
Contributions / capital 10/11€19k
Reserves 13€130k
Amounts payable 17/49€396k
Amounts payable within one year 42/48€388k
Trade debts payable within one year 44€3k
Income statement
Gross operating margin 9900€422k
Operating result 9901€318k
Financial charges 65€8k
Result before taxes 9903€310k
Income taxes 67/77€73k
Net result for the period 9904€236k
Result to be appropriated 9905€236k
This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
63 / 100 Healthy
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Monseigneur Callewaertstr.(Mar) 208510 Kortrijk

Establishment units

1 location
VANDENDRIESSCHE TINE DR. ANESTHESIE
Monseigneur Callewaertstr.(Mar) 20, 8510 KortrijkActiviteiten van medisch specialisten
since 20182.278.473.481
Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
All acts · 1 updated 1 year ago
2024
26-09-2024 Articles of association amended, translation of the articles, coordination of the articles and full restatement of the articles Statutes amendment·Jean-Charles De Witte
Summary: De vennootschap heeft tot voorwerp de uitoefening van de volledige praktijk geneeskunde door geneesheren-vennoten, met inbegrip van het ter beschikking stellen van middelen, het inrichten van diensten…Notary: Jean-Charles De Witte · KortrijkFirm: West Notarissen

Analysis

Financial profile

5 of 5 axes measured
Health63Profitability100Solvency33Growth58Stability100
71 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 63
Profitability 100
Solvency 33
Growth 58
Stability 100

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL TIVA
Registered office
Monseigneur Callewaertstr.(Mar) 20
8510 Kortrijk, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.